Participants 0 132 8
A randomized trial comparing intravesical instillations of mitoxantrone and doxorubicin in patients with superficial bladder cancer.
Participants 192 354 4
the efficacy and side effects of intravesical mitoxantrone instillation with those of doxorubicin in superficial bladder cancer following transurethral resection.
Participants 355 441 8
METHODS Sixty-three patients were randomized into mitoxantrone and doxorubicin groups.
Participants 442 513 7
Most of the patients enrolled were elderly people (mean age, 71 years).
Participants 1665 1746 3
patients with pulmonary tuberculosis or aged patients with primary bladder tumors
